110 related articles for article (PubMed ID: 187990)
21. 17-Hydroxyprogesterone level as a marker for corpus luteum function in aborters versus nonaborters.
Check JH; Vaze MM; Epstein R; Wu CH; Quattrocchi J; Vetter B
Int J Fertil; 1990; 35(2):112-5. PubMed ID: 1970979
[TBL] [Abstract][Full Text] [Related]
22. Identification of material with paternal HLA antigen immunoreactivity from purported circulating immune complexes in patients with gestational trophoblastic neoplasia.
Lahey SJ; Steele G; Berkowitz R; Rodrick ML; Ross DS; Goldstein DP; Zamcheck N; Wilson RE; Deasy JM
J Natl Cancer Inst; 1984 May; 72(5):983-90. PubMed ID: 6325794
[TBL] [Abstract][Full Text] [Related]
23. Comparison of 2 commercially available human chorionic gonadotropin immunoassays used in the management of gestational trophoblastic neoplasia.
Matsui H; Kihara M; Usui H; Tate S; Mitsuhashi A; Shozu M
J Reprod Med; 2009 Oct; 54(10):631-5. PubMed ID: 20677483
[TBL] [Abstract][Full Text] [Related]
24. Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia.
Cole LA; Butler SA; Khanlian SA; Giddings A; Muller CY; Seckl MJ; Kohorn EI
Gynecol Oncol; 2006 Aug; 102(2):151-9. PubMed ID: 16631241
[TBL] [Abstract][Full Text] [Related]
25. Natural history of partial molar pregnancy.
Berkowitz RS; Goldstein DP; Bernstein MR
Obstet Gynecol; 1985 Nov; 66(5):677-81. PubMed ID: 2414703
[TBL] [Abstract][Full Text] [Related]
26. Clinical and laboratory investigation of a virilized woman with placental-site trophoblastic tumor.
Nagelberg SB; Rosen SW
Obstet Gynecol; 1985 Apr; 65(4):527-34. PubMed ID: 2984618
[TBL] [Abstract][Full Text] [Related]
27. New criteria for the diagnosis of gestational trophoblastic disease.
Romero R; Horgan JG; Kohorn EI; Kadar N; Taylor KJ; Hobbins JC
Obstet Gynecol; 1985 Oct; 66(4):553-8. PubMed ID: 2995891
[TBL] [Abstract][Full Text] [Related]
28. Outcome of pregnancies occurring before completion of human chorionic gonadotropin follow-up in patients with persistent gestational trophoblastic tumor.
Tuncer ZS; Bernstein MR; Goldstein DP; Berkowitz RS
Gynecol Oncol; 1999 Jun; 73(3):345-7. PubMed ID: 10366457
[TBL] [Abstract][Full Text] [Related]
29. Maternal serum levels of estradiol, progesterone and human chorionic gonadotropin in ectopic pregnancy and their correlation with endometrial histologic findings.
Guillaume J; Benjamin F; Sicuranza B; Wang CF; Garcia A; Friberg J
Surg Gynecol Obstet; 1987 Jul; 165(1):9-12. PubMed ID: 3589936
[TBL] [Abstract][Full Text] [Related]
30. [Effects of primary chemotherapy with single methotrexate on low-risk gestational trophoblastic neoplasia and influencing factors thereof].
Chen YX; Shen YM; Qian JH; Xie X
Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2109-12. PubMed ID: 16313819
[TBL] [Abstract][Full Text] [Related]
31. Theca lutein ovarian cyst may be pathognomonic for trophoblastic neoplasia.
Kohorn EI
Obstet Gynecol; 1983 Sep; 62(3 Suppl):80s-81s. PubMed ID: 6308531
[TBL] [Abstract][Full Text] [Related]
32. hCG, its free subunits and its metabolites. Roles in pregnancy and trophoblastic disease.
Cole LA
J Reprod Med; 1998 Jan; 43(1):3-10. PubMed ID: 9475142
[TBL] [Abstract][Full Text] [Related]
33. Advances in the clinical laboratory detection of gestational trophoblastic disease.
Seki K; Matsui H; Sekiya S
Clin Chim Acta; 2004 Nov; 349(1-2):1-13. PubMed ID: 15469850
[TBL] [Abstract][Full Text] [Related]
34. Predicting gestational trophoblastic neoplasia (GTN): is urine hCG the answer?
Alazzam M; Young T; Coleman R; Hancock B; Drew D; Wilson P; Tidy J
Gynecol Oncol; 2011 Sep; 122(3):595-9. PubMed ID: 21684585
[TBL] [Abstract][Full Text] [Related]
35. Circulating immune complex levels in patients with gestational trophoblastic neoplasia.
Rayner AA; Berkowitz R; Steele G; Schur PH; Rodrick ML; Goldstein DP; Harte PJ; Wilson RE; Zamcheck N; Munroe AE
J Natl Cancer Inst; 1982 Jul; 69(1):23-6. PubMed ID: 6285061
[TBL] [Abstract][Full Text] [Related]
36. Low risk of relapse after achieving undetectable HCG levels in women with partial molar pregnancy.
Wolfberg AJ; Growdon WB; Feltmate CM; Goldstein DP; Genest DR; Chinchilla ME; Berkowitz RS; Lieberman ES
Obstet Gynecol; 2006 Aug; 108(2):393-6. PubMed ID: 16880311
[TBL] [Abstract][Full Text] [Related]
37. Changes in serum alpha-fetoprotein and chorionic gonadotropin in response to cancer therapy.
Nisselbaum JS; Bosl GJ; Golbey RB; Schwartz DC; Schwartz MK
Ann Clin Lab Sci; 1984; 14(3):179-88. PubMed ID: 6203466
[TBL] [Abstract][Full Text] [Related]
38. Human chorionic gonadotropin and free subunits' serum levels in patients with partial and complete hydatidiform moles.
Berkowitz R; Ozturk M; Goldstein D; Bernstein M; Hill L; Wands JR
Obstet Gynecol; 1989 Aug; 74(2):212-6. PubMed ID: 2473429
[TBL] [Abstract][Full Text] [Related]
39. [The kinetics of chorionic gonadotropin and its subunits in normal pregnancy and gestational trophoblastic neoplasms].
Kunhardt J; Calderón J; RodrÃguez S; Fletcher P; Ayala A; Reyes V
Ginecol Obstet Mex; 1987 Jul; 55():188-91. PubMed ID: 2484840
[No Abstract] [Full Text] [Related]
40. The hCG assay in the treatment of trophoblastic disease.
Pattillo RA; Hussa RO
J Reprod Med; 1984 Nov; 29(11):802-12. PubMed ID: 6097684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
